End Taxpayer Funding for Abortion Providers ActThis bill prohibits federal funding for entities, or their affiliates, that perform abortions, provide referrals for abortions, or provide funding to others that perform abortions. It provides exceptions for abortions (1) in the case of rape or incest, or (2) when a physician certifies there is a danger of death to the woman without an abortion. The bill’s prohibition applies to any federal statutory law adopted after the bill’s effective date, unless such law contains an explicit exemption.
The HCT/P Modernization Act of 2025This bill requires the Food and Drug Administration (FDA) to provide information to stakeholders and report on the regulation of human cell and tissue products, also referred to as human cells, tissues, or cellular or tissue-based products (HCT/Ps), which are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.The bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion with them on advancing the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and submit to Congress a report with recommendations on regulating these products. Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group and best practices for obtaining a recommendation about products from them. Also, annually for three years, the FDA must publish on its website information on the inquiries submitted and average response times for the Tissue Reference Group, as well as the number of human cell and tissue manufacturers that have registered with the FDA and the number of inspections the FDA has conducted with respect to these manufacturers since 2019. (The Tissue Reference Group is a working group within the FDA that receives product-specific questions from, and provides recommendations for, stakeholders on the regulation of human cell and tissue products under the FDA’s rules.)
Protecting the Dignity of Unborn Children Act of 2025 This bill establishes a new federal criminal offense for recklessly disposing of or abandoning fetal remains in a landfill or in any navigable waters of the United States.The term fetal remains means any part (except a cremated part) of a deceased human fetus following an abortion.A violator is subject to a fine, up to three years in prison, or both.
A bill for an act relating to medication abortions including required informed consent and the dispensing of abortion-inducing drugs to patients within the state.(Formerly HSB 186.)
Adoption Information ActThis bill requires federally funded family planning programs to provide each person who inquires about medical or abortion services with specified information about adoption centers in their region. The Department of Health and Human Services must provide the programs with pamphlets containing the required information.
A bill for an act relating to medication abortions including required informed consent and the dispensing of abortion-inducing drugs to patients within the state.(See HF 775.)
Standing with Moms ActThis bill requires the Department of Health and Human Services (HHS) to disseminate information about pregnancy-related resources, including information about abortion risks and alternatives.Specifically, HHS must create a public website called life.gov that lists such resources that are available through federal, state, and local governments and private entities.Additionally, HHS must create on its existing website a portal that provides a user, based on the user's responses to a series of questions, tailored information about pregnancy resources available in the user's zip code and risks related to abortion. HHS must develop a plan to conduct follow-up outreach to users of the portal (if the user consents to the outreach). States must recommend resources that meet criteria set by HHS for inclusion in the portal. HHS may award grants to states to establish or support a system that aggregates resources to include in the portal.Further, the Health Resources and Services Administration must share information about the new website and portal through the National Maternal Mental Health Hotline.HHS must also ensure that the new website and hotline are available to families who speak languages other than English.The new website, portal, and hotline may not include resources provided by entities that (1) perform, induce, refer for, or counsel in favor of abortions; or (2) financially support such entities.The bill also requires HHS to report on traffic to the new website and portal, gaps in services available to pregnant and postpartum individuals, and related matters.
No Subsidies for Wealthy Universities ActThis bill limits the indirect costs that are allowable under federal research awards to institutions of higher education (IHEs) with endowments above specified thresholds. (Generally, indirect costs represent expenses that are not specific to a research project but are needed to maintain the infrastructure and administrative support for federally funded research.)Specifically, the National Center for Education Statistics (NCES) must annually collect information regarding the endowments of each IHE that has entered into a program participation agreement with the Department of Education.With this collected information, NCES must identify and make lists of (1) each IHE with an endowment of more than $5 billion, and (2) each IHE with an endowment of more than $2 billion (but not more than $5 billion). NCES must submit these lists to the Office of Management and Budget, which must then distribute the lists to federal agencies, Congress, and the public.The bill establishes the following limits on the indirect costs allowable under federal research awards:for an IHE with an endowment of more than $5 billion, the IHE is prohibited from using these awards for indirect costs;for an IHE with an endowment of more than $2 billion (but not more than $5 billion), the IHE is limited to an indirect cost rate of 8%; andfor all other IHEs, an indirect cost rate of 15%.The Government Accountability Office must annually report to Congress on indirect cost reimbursement on federal research awards for IHEs.
Relating to insurance coverage for the disposition of embryonic and fetal tissue remains.
Prohibits using cadaveric fetal tissue obtained from elective abortion procedure for research purposes and using any cadaveric fetal tissue to research cosmetic treatments.